Home > Healthcare > Medical Devices > Medical Supplies > Anesthesia CO2 Absorbents Market

Anesthesia CO2 Absorbents Market - By Product (Medisorb, Dragersorb, Amsorb, Litholyme, Soda Lime), By Type (Premium, Traditional), By Form (Power Form, Granular Form), By End-use (Hospitals, Clinics)– Global Forecast, 2023-2032

  • Report ID: GMI7093
  • Published Date: Oct 2023
  • Report Format: PDF

Anesthesia CO2 absorbents Market Size

Anesthesia CO2 Absorbents Market size was valued at USD 74.1 million in 2022 and is estimated to account for USD 121.9 million by 2032. The anesthesia CO2 absorbents are responsible for removing carbon dioxide (CO2) from the exhaled breath of a patient under anesthesia. The increasing number of surgical procedures worldwide is one of the major factors driving the market growth.
 

Anesthesia CO2 Absorbents Market

According to the Society of Thoracic Surgeons (STS) in 2022, around 1.3 million cardiovascular procedures were carried out in North America. Hence, increasing number of cardiovascular procedures is expected to raise the demand for anesthesia CO2 absorbents, which is projected to further stimulate market progress.
 

Advances in anesthesia delivery systems and CO2 absorbent technologies have improved safety, efficiency, and effectiveness in administering anesthesia. Healthcare providers are increasingly adopting these advanced systems to enhance patient care, thereby driving market growth. Thus, the aforementioned factors will positively influence the demand for anesthesia CO2 absorbents.
 

COVID-19 Impact

The COVID-19 pandemic led to a surge in the demand for ventilators and anesthesia machines to support patients with severe respiratory issues. These machines require CO2 absorbents to function effectively. As a result, there was an increased demand for anesthesia CO2 absorbents to support the influx of COVID-19 patients. Therefore, the continued adoption of mechanical ventilators and anesthesia machines throughout the pandemic stimulated the market expansion.
 

Anesthesia CO2 Absorbents Market Trends

The global market is primarily driven by growing burden of chronic diseases globally. Chronic diseases often require surgical interventions for treatment or management. With a growing population of individuals suffering from chronic conditions such as heart disease, cancer, diabetes, and respiratory disorders, the number of surgical procedures, both elective and non-elective, will increase thereby directly contributing to the demand for anesthesia services and CO2 absorbents.
 

  • According to the WHO, chronic diseases are the leading cause of death globally, accounting for nearly 71% of all deaths worldwide.
     
  • Growing demand for anesthesia CO2 absorbents as healthcare providers aim to provide safe and effective anesthesia services for a population will favor market growth.   
     

Anesthesia CO2 Absorbents Market Analysis

Anesthesia CO2 Absorbents Market Size, By Product, 2021 - 2032 (USD Million)

The market by product is categorized into soda lime, medisorb, dragersorb, amsorb, litholyme, and other products. The medisorb segment garnered USD 23.3 million revenue size in the year 2022.
 

  • Medisorb plays a critical role in preventing rebreathing and removing exhaled carbon dioxide, along with maintaining proper gas exchange during surgery. Hence, as the number of surgeries increases the demand for Medisorb to ensure patient safety is set to increase.
     
  • It has prolonged usage capacity that makes it particularly cost-effective. Thus, aforementioned factors are likely to drive up demand for medisorb anesthesia CO2 absorbent.
     
Anesthesia CO2 Absorbents Market Share, By Type, 2022

Based on type, the anesthesia CO2 absorbents market is segmented into premium and traditional. The premium type of segment dominated the market and accounted for over 62% business share in the year 2022.
 

  • High segment growth is attributed to its advanced features and benefits compared to traditional ones.
     
  • Additionally, premium absorbents provide consistent CO2 absorption throughout their usage, which is critical for maintaining stable anesthesia levels and minimizing the risk of hypercapnia.
     

The anesthesia CO2 absorbents market by form is categorized into powder form, granular form. The powder form segment garnered USD 41.6 million revenue size in the year 2022.
 

  • Powdered CO2 absorbents often have a higher surface area and reactivity compared to granular or solid forms. This can lead to more efficient and rapid CO2 absorption, ensuring that exhaled CO2 is effectively removed from the breathing circuit.
     
  • Furthermore, powder form offers lower resistance to the flow of gases, that can be beneficial in maintaining the efficiency of the anesthesia monitoring devices market space which is estimated to reach USD 2.4 billion by the end of 2032, thus help in reducing the work of the ventilator.
     

The anesthesia CO2 absorbents market by end-use is categorized into hospitals, clinics, and others. Hospitals held over 45% of industry share in 2022.

  • Presence of skilled healthcare professionals, advanced equipment in hospital settings will favor the business landscape.
     
  • Enhanced health coverage for hospital-based healthcare services from several private and group insurance plans, among others, is further projected to contribute towards market growth.
     
U.S. Anesthesia CO2 Absorbents Market Size, 2020 -2032 (USD Million)

U.S. anesthesia CO2 absorbents market accounted for USD 20.9 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

  • Technological advancements coupled with substantial healthcare expenditure are the factors driving the market growth. Increasing number of surgeries owing to rising geriatric population further stimulates the demand for anesthesia CO2 absorbents
     
  • Major players in the industry are focusing on development of advanced anesthesia CO2 absorbents thereby creating new opportunities for the U.S. market share.
     

Anesthesia CO2 absorbents Market Share

The anesthesia CO2 absorbents industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Drägerwerk AG & Co. KGaA holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Drägerwerk AG & Co. KGaA introduced the Drägersorb 800 HEPA, in order to offer more safe and effective anesthesia CO2 absorbents in the market.
 

Some of the eminent market participants operating in the anesthesia CO2 absorbents industry include:

  • 3M
  • Baxter International
  • GE Healthcare
  • Cardinal Health
  • Beijing Kingst Commercial & Trade Co., Ltd.
  • Ecolab Inc
  • Medline Industries, Inc.
  • Philips Healthcare
  • Kimberly-Clark Corporation
  • Teleflex Incorporated
  • Thermo Fisher Scientific
  • SunMed
  • Becton Dickinson and Company
  • M.E.D. Medical Products GmbH
  • Armstrong Medical
     

Anesthesia CO2 Absorbents Industry News:

  • In May 2023, SunMed acquired respiratory & anesthesia consumables business unit of Vyaire Medical’s. This strategy led SunMed to enhance its respiratory and anesthesia medical products to support the best outcomes for patients.
     
  • In December 2021, Smith Medical launched EchoGlo peripheral nerve block product range, an addition to Portex pain management product line. It offers customers a complete solution for local anesthesia, thereby benefiting the company in expanding its customer base and sustaining its market position.
     

Anesthesia CO2 absorbents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


By Product, 2018-2032 (USD Million & Units)

  • Medisorb
  • Soda lime
  • Dragersorb
  • Amsorb
  • Litholyme
  • Other products

By Type, 2018-2032 (USD Million)

  • Premium
  • Traditional

By Form, 2018-2032 (USD Million)

  • Powder form
  • Granular form

By End-use, 2018-2032 (USD Million)

  • Hospitals
  • Clinics
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
       
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Anesthesia CO2 absorbents industry was worth USD 74.1 million in revenue in 2022 and is projected to reach USD 121.9 million by 2032 driven by increasing usage in the surging number of surgical procedures globally.

Anesthesia CO2 absorbents industry size from the medisorb segment generated USD 23.3 million in 2022 and is set to witness high demand through 2032 owing to rising application in surgeries to offer prolonged use capacity and cost-effectiveness.

U.S. anesthesia CO2 absorbents industry generated USD 20.9 million in revenue in 2022 and is estimated to expand at notable CAGR from 2023-2032 owing to higher technological advancements coupled with substantial healthcare expenditure in the region.

Some of the major anesthesia CO2 absorbents companies are 3M, Baxter International, GE Healthcare, Cardinal Health, Beijing Kingst Commercial & Trade Co., Ltd., Ecolab Inc., Medline Industries, Inc., Philips Healthcare, Teleflex Incorporated, and Thermo Fisher Scientific.

Anesthesia CO2 Absorbents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 347
  • Countries covered: 18
  • Pages: 175
 Download Free Sample